QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: GVP Module VI — Collection, Management and Submission of ICSRs

Test your understanding of the concepts covered by GVP Module VI: Collection, Management and Submission of Reports of Suspected Adverse Reactions to Medicinal Products.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A product-quality complaint includes a patient who developed a suspected adverse reaction. What control is most important?

Keep the information exclusively within the quality system Define an interface that transfers the safety information to pharmacovigilance within controlled timelines Wait for manufacturing investigation results before assessing the adverse reaction Treat the complaint as non-reportable because it originated outside pharmacovigilance

Question 2 of 10 Several serious ICSRs were submitted late because an intake mailbox was not monitored outside normal business hours. Which CAPA is most likely to address the root cause?

Retrain only the processors who eventually handled the cases Improve out-of-hours mailbox monitoring, ownership, escalation and reconciliation controls Reduce the amount of information captured in future cases Close the cases more quickly after they are created

Question 3 of 10 Which practice best supports reliable regulatory timeline control?

Use a single internal target without considering report characteristics Determine deadlines using controlled rules and inputs such as receipt date, seriousness, source, territory and reporting obligation Start the clock only when the case is medically reviewed Monitor only the percentage of cases submitted on time

Question 4 of 10 Which set of records would best allow an inspector to reconstruct an ICSR lifecycle?

Only the final submitted case and the current database status Receipt evidence, case history, source documentation, assessments, follow-up, submission acknowledgement and quality records Only the processor's training certificate and the product label A summary metric showing the overall percentage of timely submissions

Question 5 of 10 Which statement best describes proportionate QPPV oversight of ICSR management?

The QPPV must personally review every individual case The QPPV should have visibility of material weaknesses and significant risks without needing to personally review every case The QPPV is responsible only for product-specific causality decisions The QPPV should receive metrics but not information about deviations or system failures

Question 6 of 10 What is the primary purpose of reconciliation between an internal safety database and a regulatory gateway?

To replace medical review with an automated comparison To identify discrepancies, losses, duplications or transmission problems across the interface To determine whether every event is causally related to the product To eliminate the need for submission acknowledgements

Question 7 of 10 A consumer reports that an individual patient experienced nausea after using a medicinal product, but provides no patient name. The consumer can be identified as the source. Which is the most appropriate initial interpretation?

The report is invalid because the patient's name is missing The report may meet the minimum criteria if the patient is identifiable through other information The report is valid only if a healthcare professional confirms causality The report should be rejected until the complete medical history is obtained

Question 8 of 10 An MAH outsources case processing to a vendor. Which responsibility remains with the MAH?

None, once the contract has been signed Oversight of receipt, timelines, quality, reconciliation, escalation and vendor performance Only responsibility for the vendor's employee training records Responsibility only for cases that the vendor fails to process

Question 9 of 10 A processor considers an event medically plausible for a medicinal product and therefore classifies it as expected. What is the main problem with this approach?

Expectedness must be assessed against the applicable reference safety information and reporting framework Expectedness is determined only by the patient's outcome Expectedness is identical to seriousness Expectedness can be assessed only after a duplicate has been identified

Question 10 of 10 What should be documented when a follow-up attempt is made but no response is received?

Only the fact that the case remained incomplete The information requested, date, communication method, response status and any stopping rationale A presumption that the requested information was negative A new ICSR containing the unanswered questions

QPPV.com

Knowledge Assessment: GVP Module VI — Collection, Management and Submission of ICSRs

Cookie Settings